-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The spread of SARS-CoV-2 and the global pandemic of Covid-19 continue
New Coronary Pneumonia Immunity Recently, researchers examined the efficacy of the new coronary pneumonia vaccine in people with deficient immune systems
The seroconversion rate of each group after the first vaccination
The seroconversion rate of each group after the first vaccinationThe study found that seroconversion rates after Covid-19 vaccination in immunocompromised .
The seroconversion rate after Covid-19 vaccination in
immunocompromised .
In all patient groups, the second dose was associated with increased seroconversion, and the third dose resulted in seroconversion in previously non-responders .
The seroconversion rate after Covid-19 vaccination in immunocompromised .
In all patient groups, the second dose was associated with increased seroconversion, and the third dose resulted in seroconversion in previously non-responders .
Original source: Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis.
Leave a comment here